TScan Therapeutics (TCRX) SEC Filings & 10K Form

$8.98
+0.08 (+0.90%)
(As of 05/17/2024 ET)

Recent TScan Therapeutics SEC Filings

DateFilerForm TypeView
05/13/2024
6:15 AM
TScan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
6:30 AM
TScan Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2024
3:05 PM
Louis Chrystal (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
3:17 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
3:25 PM
BAKER BROS. ADVISORS LP (Filed by)
TScan Therapeutics (Subject)
Form SC 13D/A
04/23/2024
3:15 PM
Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
8:58 PM
TScan Therapeutics (Filer)
Form 424B5
04/17/2024
5:25 AM
TScan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2024
5:20 AM
TScan Therapeutics (Subject)
Form FWP
04/16/2024
4:21 PM
TScan Therapeutics (Filer)
Form 424B5
04/16/2024
3:16 PM
TScan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2024
11:15 PM
TScan Therapeutics (Filer)
Form EFFECT
04/10/2024
6:30 AM
TScan Therapeutics (Filer)
Form 10-K/A
04/08/2024
7:17 AM
TScan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
6:30 AM
TScan Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2024
6:15 AM
TScan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
3:45 PM
K2 HealthVentures Equity Trust LLC (Filed by)
TScan Therapeutics (Subject)
Form SC 13G/A
02/08/2024
5:02 AM
Pitango HealthTech Fund I, L.P. (Filed by)
TScan Therapeutics (Subject)
Form SC 13G/A
02/07/2024
6:45 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
TScan Therapeutics (Subject)
Form SC 13G/A
02/02/2024
3:21 PM
Amello Jason (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
6:15 AM
TScan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2023
4:00 PM
BARBERICH TIMOTHY J (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
5:01 PM
Klencke Barbara (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
7:00 AM
TScan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2023
7:15 AM
TScan Therapeutics (Issuer)
TScan Therapeutics (Issuer)
Woods Keith (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/08/2023
7:20 AM
TScan Therapeutics (Issuer)
TScan Therapeutics (Issuer)
Woods Keith (Reporting)
Woods Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
6:15 AM
TScan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
6:15 AM
TScan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
6:30 AM
TScan Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2023
6:30 AM
TScan Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2023
6:15 AM
TScan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2023
6:39 PM
Dworak Leiden (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2023
6:31 PM
Dworak Leiden (Reporting)
TScan Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/29/2023
7:30 AM
TScan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2023
3:38 PM
TScan Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/15/2023
5:25 PM
BARBERICH TIMOTHY J (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
5:01 PM
TScan Therapeutics (Issuer)
ZDRAVESKI ZORAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
5:08 PM
MacBeath Gavin (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
5:09 PM
Silver Brian M. (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
5:13 PM
Klencke Barbara (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
5:14 PM
Gruia Gabriela (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Biden Nomination CANCELED? (Ad)

The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?

I believe I have the terrifying answer right here.
06/15/2023
5:17 PM
Dorton Katina (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
5:19 PM
Barton Debora (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
3:40 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
12:25 PM
BlackRock Inc. (Filed by)
TScan Therapeutics (Subject)
Form SC 13G/A
06/06/2023
6:53 PM
BARBERICH TIMOTHY J (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
3:45 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
TScan Therapeutics (Subject)
Form SC 13G
06/02/2023
4:33 PM
Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
TScan Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/02/2023
4:35 PM
Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
7:00 AM
TScan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2023
7:16 AM
TScan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/26/2023
7:12 PM
TScan Therapeutics (Filer)
Form 424B5
05/26/2023
5:42 AM
TScan Therapeutics (Subject)
Form FWP
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:TCRX) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners